HEPATIC FUNCTION ABNORMAL

Clinical trials for HEPATIC FUNCTION ABNORMAL explained in plain language.

Never miss a new study

Get alerted when new HEPATIC FUNCTION ABNORMAL trials appear

Sign up with your email to follow new studies for HEPATIC FUNCTION ABNORMAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 2 Terminated 1

Drug safety test halted: how liver health changes medication

Knowledge-focused Terminated

This study aimed to understand how liver function affects the processing of the breast cancer drug amcenestrant. It involved 13 female participants, some with mild to moderate liver impairment and others with normal liver function, who received a single dose. The main goal was to…

Matched conditions: HEPATIC FUNCTION ABNORMAL

Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:42 UTC

HEPATIC FUNCTION ABNORMAL

Get alerted when new HEPATIC FUNCTION ABNORMAL trials appear

Drug safety test halted: how liver health changes medication